3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
51
Neoplasm Metastasis
19
Skin Neoplasms
15
Carcinoma, Renal Cell
13
Leukemia, Myeloid, Acute
12
Kidney Neoplasms
11
Leukemia
9
Neoplasms
7
Uterine Cervical Neoplasms
5
Lymphoma
5
Congenital Abnormalities
5
Breast Neoplasms
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Pancreatic Neoplasms
4
Ovarian Neoplasms
4
Neuroblastoma
4
Myelodysplastic Syndromes
4
Lymphoma, Non-Hodgkin
4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
4
Carcinoma, Non-Small-Cell Lung
4
Vaginal Neoplasms
2
Penile Neoplasms
2
Papillomavirus Infections
2
Oropharyngeal Neoplasms
2
Melanoma, Experimental
2
Lymphoma, Mantle-Cell
2
Leukemia, Megakaryoblastic, Acute
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia, Erythroblastic, Acute
2
Brain Neoplasms
2
Interventions
Zoledronic Acid
2
Vincristine
2
Temozolomide
2
Radiosurgery
2
Magnetic Resonance Spectroscopy
2
Irinotecan
2
Doxorubicin
2
Cyclophosphamide
2
selinexor
1
saracatinib
1
samarium Sm-153 lexidronam
1
robatumumab
1
pembrolizumab
1
pegfilgrastim
1
angiotensin I (1-7)
1
Transcranial Direct Current Stimulation
1
Tranexamic Acid
1
Sunitinib
1
Standard of Care
1
Sodium Pertechnetate Tc 99m
1
Sodium Chloride
1
Samarium
1
Radiation
1
Proton Therapy
1
Pregabalin
1
Practice Guidelines as Topic
1
Plicamycin
1
Palliative Care
1
Nivolumab
1
Neutrons
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Bone Neoplasms
×
aldesleukin
×
Clear all
No trials found.